论文部分内容阅读
Objective A programmed nanosystem for the sequential and site-specific co-delivery of KIAA1199 specific shRNA and paclitaxel was formulated to treat breast cancer through combination therapy of cooperatively inhibiting tumor cells proliferation and metastasis.